Control of Communicable Diseases: Foreign; Requirements Relating to Collection, Storage, and Transmission of Airline and Vessel Passenger, Crew, and Flight and Voyage Information for Public Health Purposes, 3451-3452 [2019-02035]
Download as PDF
<![CDATA[
3451
Federal Register / Vol. 84, No. 29 / Tuesday, February 12, 2019 / Notices
of invitation to its former blood testing
program participants. To achieve the
desired sample size, the other 11
percent of the exposure group (n=150,
or 50 per year) will be recruited in Wave
Two. These will be people who were
eligible for the PFAS blood testing
program but did not take part. The
referent group will be recruited in Wave
Three (n=275, or 92 per year), which
can occur concurrently with Wave One
and Wave Two. Wave Two and Wave
Three recruits will call to volunteer after
ATSDR opens those waves to
enrollment.
To restrict this study to drinking
water exposures, any adult
occupationally exposed to PFAS will
not be eligible for the study (i.e., ever
firefighters or in chemical manufacture).
Likewise, children whose birth mothers
were occupationally exposed will not be
eligible. This restriction applies to both
the exposure and the referent group.
ATSDR assumes that five percent of the
people who volunteer will not meet
eligibility requirements. ATSDR will
screen the 1,578 people from the NH
DHHS PFAS blood testing program in
Wave One (n=526 per year). ATSDR will
screen at least 198 exposed people in
Wave Two (or 66 per year), and at least
362 unexposed people in Wave Three
(or 121 per year). This will require an
annual time burden of 134 hours for
eligibility screening.
At enrollment, ATSDR will obtain
adult consent, parental permission, and
child assent before data collection
begins. Each child will enroll with a
parent, who ideally will be the child’s
birth mother, as ATSDR will ask details
about the child’s exposure, pregnancy,
and breastfeeding history.
For each participant, ATSDR will take
body measures, collect blood and urine
samples for chemical and biomarker
analysis, and administer a questionnaire
on exposures and medical history. For
purposes of burden estimation, ATSDR
assumes that 20 percent of parents will
also enroll as adults; therefore, 420
parents will take the child questionnaire
long form (n=140 per year), while 105
parents will take the short form to
reduce burden (n=35 per year). Parents
and children will also complete
assessments of the child’s attention and
behaviors. After eligibility screening,
the annual time burden for participation
in the study is 58 hours for adults and
208 hours for children and their parents.
ATSDR will ask for permission to
compare adults’ and children’s medical
histories with their medical records.
ATSDR will also ask for permission to
check children’s school records to
compare their behavioral assessment
results. The annual time burden for
medical record abstraction is estimated
to be 183 hours. The annual time
burden for school record abstraction is
estimated to be 60 hours.
The total annualized time burden
requested is 1,199 hours. There is no
cost to the respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Type of respondents
Form name
Pease Study Participants ................................
Wave One Eligibility Screening Script ...........
Wave Two Eligibility Screening Script ...........
Wave Three Eligibility Screening Script .........
Appointment Reminder Telephone Script ......
Update Contact Information Hardcopy Form
Medication List ...............................................
Body and Blood Pressure Measures Form ...
Blood Draw and Urine Collection Form .........
Adult Questionnaire ........................................
Child Questionnaire—Long Form ..................
Child Questionnaire—Short Form ..................
Parent Neurobehavioral Test Battery ............
Child Neurobehavioral Test Battery ...............
Child School Record Abstraction Form .........
Medical Record Abstraction Form—Adult ......
Medical Record Abstraction Form—Child ......
Education Specialists ......................................
Medical Record Specialists .............................
Jeffrey M. Zirger,
Acting Lead, Information Collection Review
Office, Office of Scientific Integrity, Office
of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2019–01992 Filed 2–11–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2019–0008]
Control of Communicable Diseases:
Foreign; Requirements Relating to
Collection, Storage, and Transmission
of Airline and Vessel Passenger, Crew,
and Flight and Voyage Information for
Public Health Purposes
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:
VerDate Sep<11>2014
18:30 Feb 11, 2019
Jkt 247001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
526
66
121
542
542
542
542
542
367
140
35
175
175
15
25
25
Number of
responses per
respondent
1
1
1
1
1
1
1
1
1
1
1
1
1
12
15
7
Average
burden per
response
(in hours)
10/60
15/60
15/60
5/60
5/60
3/60
5/60
10/60
30/60
30/60
15/60
15/60
90/60
20/60
20/60
20/60
The Centers for Disease
Control and Prevention (CDC) in the
Department of Health and Human
Services (HHS) announces the opening
of a docket to obtain comment on a
report as required by agency rules that
relate to the transmission of passenger,
crew, and flight/voyage information for
public health purposes. The report can
be found at https://www.cdc.gov/
quarantine/final-rule-communicablediseases.html. Interested members of the
public may submit comment regarding
this report.
SUMMARY:
Written comments must be
received on or before March 14, 2019.
DATES:
E:\FR\FM\12FEN1.SGM
12FEN1
3452
Federal Register / Vol. 84, No. 29 / Tuesday, February 12, 2019 / Notices
You may submit comments,
identified by Docket No. CDC–2019–
0008 by any of the following methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H16–4, Atlanta, Georgia 30329;
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to https://regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: For
questions concerning this notice: Ashley
C. Altenburger, JD, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, Mailstop H16–4, Atlanta,
Georgia 30329; telephone 404–498–
1600; email dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data.
Please note that comments received,
including attachments and other
supporting materials, are part of the
public record and are subject to public
disclosure. Comments will be posted on
https://www.regulations.gov. Therefore,
do not include any information in your
comment or supporting materials that
you consider confidential or
inappropriate for public disclosure. If
you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be on
public display. CDC will review all
submissions and may choose to redact,
or withhold, submissions containing
private or proprietary information such
as Social Security numbers, medical
information, inappropriate language, or
duplicate/near duplicate examples of a
mass-mail campaign.
Additional Background
HHS/CDC published the final rule for
the Control of Communicable Diseases
on January 19, 2017, which included
amendments to the domestic (interstate)
and foreign quarantine regulations for
the control of communicable diseases.
The rule became effective on March 21,
2017. CDC regulations at 42 CFR 71.4
(airlines) and 42 CFR 71.5 (vessels)
relate to the transmission of passenger,
crew, and flight/voyage information for
public health purposes; both contain
subsections that state:
VerDate Sep<11>2014
18:30 Feb 11, 2019
Jkt 247001
No later than February 21, 2019, the
Secretary or Director will publish and
seek comment on a report evaluating
the burden of this section on affected
entities and duplication of activities in
relation to mandatory passenger data
submissions to [U.S. Department of
Homeland Security, Customs and
Border Patrol] DHS/CBP. The report will
specifically recommend actions that
streamline and facilitate use and
transmission of any duplicate
information collected.
On February 12, 2019, CDC published
a report to its website evaluating the
burdens these regulatory provisions may
have generated on the airline and ship
industries since they became effective
on March 21, 2017. The report can be
found at https://www.cdc.gov/
quarantine/final-rule-communicablediseases.html. The public comment
period will end on March 14, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease
Control and Prevention.
[FR Doc. 2019–02035 Filed 2–11–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Chief Operating Officer, CDC,
pursuant to Public Law 92–463. The
grant applications and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Disease, Disability,
and Injury Prevention and Control Special
Emphasis Panel (SEP)—DD19–001; Research
Approaches to Improve the Care and
Outcomes of People Living with Spina Bifida
Components A and B.
Dates: April 9–10, 2019.
Times: 10:00 a.m.–6:30 p.m., EDT.
Place: Teleconference.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
For Further Information Contact: Jaya
Raman, Ph.D., Scientific Review Officer,
CDC, 4770 Buford Highway, Mailstop F80,
Atlanta, Georgia 30341, Telephone: (770)
488–6511, kva5@cdc.gov.
The Chief Operating Officer, Centers for
Disease Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for both
the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2019–01959 Filed 2–11–19; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2019–0007]
The National Healthcare Safety
Network’s Outpatient Procedure
Component (OPC) Surveillance
Protocol and the Bloodstream
Infection (BSI) Surveillance Protocol;
Request for Information
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Request for information.
AGENCY:
The Centers for Disease
Control and Prevention, in the
Department of Health and Human
Services, seeks information related to
the surveillance protocols for the
National Healthcare Safety Network’s
(NHSN) Outpatient Procedure
Component (OPC) and Bloodstream
Infection (BSI) Module of the Patient
Safety Component. CDC is opening this
docket to provide the opportunity to
identify issues and areas for potential
improvement for consideration as CDC
updates and maintains the NHSN
surveillance protocols beginning in
2020.
SUMMARY:
Written comments will be
accepted beginning February 14, 2019
and must be received on or before April
15, 2019.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2018–
xxxx, by either of the following
methods:
• Federal eRulemaking Portal: https://
www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Katherine Allen-Bridson,
National Center for Emerging and
DATES:
E:\FR\FM\12FEN1.SGM
12FEN1
]]>Agencies
[Federal Register Volume 84, Number 29 (Tuesday, February 12, 2019)]
[Notices]
[Pages 3451-3452]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-02035]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2019-0008]
Control of Communicable Diseases: Foreign; Requirements Relating
to Collection, Storage, and Transmission of Airline and Vessel
Passenger, Crew, and Flight and Voyage Information for Public Health
Purposes
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice with comment period.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC) in the
Department of Health and Human Services (HHS) announces the opening of
a docket to obtain comment on a report as required by agency rules that
relate to the transmission of passenger, crew, and flight/voyage
information for public health purposes. The report can be found at
https://www.cdc.gov/quarantine/final-rule-communicable-diseases.html.
Interested members of the public may submit comment regarding this
report.
DATES: Written comments must be received on or before March 14, 2019.
[[Page 3452]]
ADDRESSES: You may submit comments, identified by Docket No. CDC-2019-
0008 by any of the following methods:
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Centers for Disease Control and Prevention, 1600
Clifton Road NE, Mailstop H16-4, Atlanta, Georgia 30329;
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to https://regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
FOR FURTHER INFORMATION CONTACT: For questions concerning this notice:
Ashley C. Altenburger, JD, Centers for Disease Control and Prevention,
1600 Clifton Road NE, Mailstop H16-4, Atlanta, Georgia 30329; telephone
404-498-1600; email dgmqpolicyoffice@cdc.gov.
SUPPLEMENTARY INFORMATION:
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data.
Please note that comments received, including attachments and other
supporting materials, are part of the public record and are subject to
public disclosure. Comments will be posted on https://www.regulations.gov. Therefore, do not include any information in your
comment or supporting materials that you consider confidential or
inappropriate for public disclosure. If you include your name, contact
information, or other information that identifies you in the body of
your comments, that information will be on public display. CDC will
review all submissions and may choose to redact, or withhold,
submissions containing private or proprietary information such as
Social Security numbers, medical information, inappropriate language,
or duplicate/near duplicate examples of a mass-mail campaign.
Additional Background
HHS/CDC published the final rule for the Control of Communicable
Diseases on January 19, 2017, which included amendments to the domestic
(interstate) and foreign quarantine regulations for the control of
communicable diseases. The rule became effective on March 21, 2017. CDC
regulations at 42 CFR 71.4 (airlines) and 42 CFR 71.5 (vessels) relate
to the transmission of passenger, crew, and flight/voyage information
for public health purposes; both contain subsections that state:
No later than February 21, 2019, the Secretary or Director will
publish and seek comment on a report evaluating the burden of this
section on affected entities and duplication of activities in relation
to mandatory passenger data submissions to [U.S. Department of Homeland
Security, Customs and Border Patrol] DHS/CBP. The report will
specifically recommend actions that streamline and facilitate use and
transmission of any duplicate information collected.
On February 12, 2019, CDC published a report to its website
evaluating the burdens these regulatory provisions may have generated
on the airline and ship industries since they became effective on March
21, 2017. The report can be found at https://www.cdc.gov/quarantine/final-rule-communicable-diseases.html. The public comment period will
end on March 14, 2019.
Sandra Cashman,
Executive Secretary, Centers for Disease Control and Prevention.
[FR Doc. 2019-02035 Filed 2-11-19; 8:45 am]
BILLING CODE 4163-18-P
